Related Experiment Video
Updated: Jun 8, 2025

A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
Published on: December 4, 2018
ZNFX1 is a Novel Master Regulator in Epigenetically-induced Pathogen Mimicry and Inflammasome Signaling in Cancer
Lora Stojanovic1,2, Rachel Abbotts1,2, Kaushlendra Tripathi1,2
1University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD 21201, USA.
Abstract:
DNA methyltransferase and poly(ADP-ribose) polymerase inhibitors (DNMTis, PARPis) induce a stimulator of interferon (IFN) genes (STING)-dependent pathogen mimicry response (PMR) in ovarian (OC) and other cancers. We now show that combining DNMTis and PARPis upregulates expression of a little-studied nucleic-acid sensor, NFX1-type zinc finger-containing 1 protein (ZNFX1). We demonstrate that ZNFX1 is a novel master regulator for PMR induction in mitochondria, serving as a gateway for STING-dependent PMR. In patient OC databases, high ZNFX1 expression levels correlate with advanced stage disease. ZNFX1 expression alone significantly correlates with an increase in overall survival in a phase 3 trial for therapy-resistant OC patients receiving bevacizumab in combination with chemotherapy. In correlative RNA-seq data, inflammasome signaling through ZNFX1 correlates with abnormal vasculogenesis. ZNFX1 controls PMR signaling through the mitochondria and may serve as a biomarker to facilitate offering personalized therapy in OC patients, highlighting the strong translational significance of our findings.
Insights
DNA methyltransferase and poly(ADP-ribose) polymerase inhibitors (DNMTis, PARPis) activate a pathogen mimicry response (PMR). ZNFX1 protein is a novel master regulator of this response, potentially serving as a biomarker for ovarian cancer therapy.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- DNA methyltransferase inhibitors (DNMTis) and poly(ADP-ribose) polymerase inhibitors (PARPis) induce a stimulator of interferon genes (STING)-dependent pathogen mimicry response (PMR) in ovarian cancer (OC).
- The precise molecular mechanisms and regulators of this PMR are not fully understood.
Purpose of the Study:
- To investigate the role of the nucleic-acid sensor ZNFX1 in DNMTi and PARPi-induced PMR.
- To determine ZNFX1's potential as a biomarker and therapeutic target in ovarian cancer.
Main Methods:
- Analysis of ovarian cancer patient databases and correlative RNA-sequencing data.
- Investigating ZNFX1's function in regulating mitochondrial pathogen mimicry response (PMR) and STING signaling.
Main Results:
- Combining DNMTis and PARPis upregulates ZNFX1 expression.
- ZNFX1 acts as a master regulator of mitochondrial PMR induction, serving as a gateway for STING-dependent PMR.
- High ZNFX1 expression correlates with advanced OC stage but also with increased overall survival in therapy-resistant patients treated with bevacizumab and chemotherapy.
Conclusions:
- ZNFX1 is a novel key regulator of the STING-dependent pathogen mimicry response in ovarian cancer.
- ZNFX1 may serve as a predictive biomarker for personalized therapy, particularly in combination with bevacizumab and chemotherapy for therapy-resistant ovarian cancer.
More Related Videos
08:19Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
Published on: July 20, 2019
10:57NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Master Transcription Regulators
Abnormal Proliferation
Epigenetic Regulation
Regulation of the Unfolded Protein Response
Canonical Wnt Signaling Pathway